Novartis investigational dual bronchodilator significantly improved lung function compared to single bronchodilators in patients with moderate-to-severe COPD in phase III studies

Novartis investigational dual bronchodilator significantly improved lung function compared to single bronchodilators in patients with moderate-to-severe COPD in phase III studies

May 20, 2015
Source URL: https://qa1.novartis.us/news/media-releases/novartis-investigational-dual-bronchodilator-significantly-improved-lung-function-compared-single-bronchodilators-patients-moderate-severe-copd-phase-iii-studies-0

List of links present in page
  1. https://qa1.novartis.us/news/media-releases/novartis-investigational-dual-bronchodilator-significantly-improved-lung-function-compared-single-bronchodilators-patients-moderate-severe-copd-phase-iii-studies-0